Insulet Corp

PODD: XNAS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
LOCK|tqLOCK|cg>%JLOCK|PYT$Fk^C

Insulet Earnings: Slower Growth Fails to Diminish Strong Fundamentals in 2024

Insulet increased fourth-quarter 2024 revenue by 17% in constant currency, hampered by an unfavorable comparison with the prior-year period. However, adjusted for these distributor distortions, US Omnipod revenue rose 26%, reflecting solid underlying demand.

Sponsor Center